156 related articles for article (PubMed ID: 32299849)
1. Hormone Replacement Therapy, Breast Cancer Risk Factors, and Breast Cancer Risk: A Nationwide Population-Based Cohort.
Yoo TK; Han KD; Kim D; Ahn J; Park WC; Chae BJ
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1341-1347. PubMed ID: 32299849
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
[TBL] [Abstract][Full Text] [Related]
3. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
Liu JY; Chen TJ; Hwang SJ
Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187426
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study.
Azam S; Lange T; Huynh S; Aro AR; von Euler-Chelpin M; Vejborg I; Tjønneland A; Lynge E; Andersen ZJ
Cancer Causes Control; 2018 Jun; 29(6):495-505. PubMed ID: 29671181
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy.
Manjer J; Malina J; Berglund G; Bondeson L; Garne JP; Janzon L
Int J Cancer; 2001 Jun; 92(6):919-22. PubMed ID: 11351317
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
Hou N; Hong S; Wang W; Olopade OI; Dignam JJ; Huo D
J Natl Cancer Inst; 2013 Sep; 105(18):1365-72. PubMed ID: 24003037
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
[TBL] [Abstract][Full Text] [Related]
10. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
11. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and cancer risks in perimenopausal women: A retrospective cohort study using a Japanese claims database.
Inayama Y; Mizuno K; Yamaguchi K; Hamanishi J; Takeuchi M; Egawa M; Mandai M; Kawakami K
J Obstet Gynaecol Res; 2023 Jul; 49(7):1805-1814. PubMed ID: 37029559
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
Fahlén M; Fornander T; Johansson H; Johansson U; Rutqvist LE; Wilking N; von Schoultz E
Eur J Cancer; 2013 Jan; 49(1):52-9. PubMed ID: 22892060
[TBL] [Abstract][Full Text] [Related]
15. Hormone Replacement Therapy and the Incidence of Nonarteritic Anterior Ischemic Optic Neuropathy: a Nationwide Population-Based Study (2009-2018).
Lee C; Han KD; Yoo J; Park KA; Oh SY
Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):2019-2029. PubMed ID: 36680611
[TBL] [Abstract][Full Text] [Related]
16. Do women taking hormone replacement therapy (HRT) have a higher incidence of breast cancer than women who do not?
Fleming RM
Integr Cancer Ther; 2003 Sep; 2(3):235-7. PubMed ID: 15035886
[TBL] [Abstract][Full Text] [Related]
17. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
18. [Estrogen replacement therapy and breast cancer].
Bakken K; Alsaker E; Eggen AE; Lund E
Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy regimens and breast cancer risk(1).
Weiss LK; Burkman RT; Cushing-Haugen KL; Voigt LF; Simon MS; Daling JR; Norman SA; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Berlin JA; Weber AL; Doody DR; Wingo PA; McDonald JA; Malone KE; Folger SG; Spirtas R
Obstet Gynecol; 2002 Dec; 100(6):1148-58. PubMed ID: 12468157
[TBL] [Abstract][Full Text] [Related]
20. A population-based cohort study of HRT use and breast cancer in Korea.
Park SB; Shin HR; Lee SY
Asia Pac J Public Health; 2012 Mar; 24(2):415-22. PubMed ID: 21266394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
